Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial

2015 ◽  
Vol 24 (3) ◽  
pp. 1285-1294 ◽  
Author(s):  
Matteo Lambertini ◽  
Paolo Bruzzi ◽  
Francesca Poggio ◽  
Simona Pastorino ◽  
Giovanni Gardin ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Phase Iii ◽  
Breast Cancer Patients ◽  
Single Center ◽  
Phase Iii Trial ◽  
Single Center Experience ◽  
Dose Dense

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies

2017 ◽  
Vol 71 ◽  
pp. 34-42 ◽  
Author(s):  
Matteo Lambertini ◽  
Marcello Ceppi ◽  
Francesco Cognetti ◽  
Giovanna Cavazzini ◽  
Michele De Laurentiis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adjuvant Chemotherapy ◽  
Cancer Patients ◽  
Pooled Analysis ◽  
Phase Iii ◽  
Breast Cancer Patients ◽  
Premenopausal Breast Cancer ◽  
Dose Dense ◽  
Phase Iii Studies
Sign in / Sign up

Export Citation Format

Share Document